Bioinformatics.org
|
|
Research
|
Online databases
Online analysis tools
Online education tools
|
Development
|
|
Forums
|
News & Commentary
Jobs Forum (Career Center)
|
|
News & Commentary - Message forums
|
|
|
|
At Work: National Academies: Germline editing clinical trials could one day be permitted
Submitted by J.W. Bizzaro; posted on Tuesday, February 14, 2017
|
EXCERPT
Clinical trials for genome editing of the human germline – adding, removing, or replacing DNA base pairs in gametes or early embryos – could be permitted in the future, but only for serious conditions under stringent oversight, says a new report from the National Academy of Sciences and the National Academy of Medicine. The report outlines several criteria that should be met before allowing germline editing clinical trials to go forward. Genome editing has already entered clinical trials for non-heritable applications, but should be allowed only for treating or preventing diseases or disabilities at this time.
Source: http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=24623
|
|
Expanded view | Monitor forum | Save place
Start a new thread:
You have to be to post a reply.
|
|